2024
Salvage Lung Resection after Immunotherapy is Feasible and Safe
Nemeth A, Canavan M, Zhan P, Udelsman B, Ely S, Wigle D, Martin L, Yang C, Boffa D, Dhanasopon A. Salvage Lung Resection after Immunotherapy is Feasible and Safe. JTCVS Open 2024, 20: 141-150. DOI: 10.1016/j.xjon.2024.03.018.Peer-Reviewed Original ResearchNon-small cell lung cancerComplete pathologic responseSalvage lung resectionNational Cancer DatabaseLength of stayStages I-IVLung resectionOligo-progressionOverall survivalSalvage surgeryComplete resection (R0Comprehensive multidisciplinary treatment planHigher R0 resection rateCohort study of patientsInitiation of immunotherapyR0 resection rateTreated with immunotherapySalvage treatment optionMortality rateCell lung cancerLow patient morbidityMedian length of stayKaplan-Meier analysisMultidisciplinary treatment planStudy of patientsImage-guided and bronchoscopic localization techniques used to facilitate minimally invasive pulmonary metastasectomies
Wang A, Rosenberg G, Woodard G, Dhanasopon A, Udelsman B. Image-guided and bronchoscopic localization techniques used to facilitate minimally invasive pulmonary metastasectomies. Video-Assisted Thoracic Surgery 2024, 0: 0-0. DOI: 10.21037/vats-23-80.Peer-Reviewed Original ResearchAssessment of online information on robotic cardiac and thoracic surgery
Hameed I, Amabile A, Candelario K, Khan S, Li E, Fereydooni S, Almeida M, Latif N, Ahmed A, Dhanasopon A, Krane M, Blasberg J, Geirsson A. Assessment of online information on robotic cardiac and thoracic surgery. Journal Of Robotic Surgery 2024, 18: 41. PMID: 38231324, DOI: 10.1007/s11701-023-01794-6.Peer-Reviewed Original ResearchConceptsThoracic surgeryAmount of contentConfidence intervalsOnline informationReadability of online resourcesOnline health informationSystematic online searchPerioperative informationCardiothoracic surgeonsOnline health resourcesAcademic websitesSurgeryPatientsReadability of websitesThoracicMultivariate regressionHigher accuracyWebsite accuracyPatient useHealth informationReadabilityWebsitesAccuracyAssociated with higher accuracyIndependent panel
2023
So Now We Know—Reflections on the Extent of Resection for Stage I Lung Cancer
Detterbeck F, Ely S, Udelsman B, Blasberg J, Boffa D, Dhanasopon A, Mase V, Woodard G. So Now We Know—Reflections on the Extent of Resection for Stage I Lung Cancer. Clinical Lung Cancer 2023, 25: e113-e123. PMID: 38310034, DOI: 10.1016/j.cllc.2023.12.007.Peer-Reviewed Original ResearchStage I lung cancerI lung cancerSublobar resectionRecurrence-free survivalHealthy patientsLung cancerRecent trialsInadequate resection marginsLarge recent trialsAdditional randomized trialsHigh-level evidenceOverall survival differenceExtent of resectionLong-term outcomesLong-term resultsHigh locoregional recurrenceAspects of patientsLesser resectionsLocoregional recurrencePerioperative morbidityIntraoperative detailsLung functionResection extentResection marginsPostoperative changes